Treco Douglas A

CIK 00016881923 companiesBOSTON, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001688192

Recent Transactions

42 trades

Purchase
CRISPR Therapeutics AG$CRSP
Common Shares
2025-08-06$57.03/sh+20,000→ 22,000 total
Disposition to Issuer
Inozyme Pharma, Inc.
Stock Option (Right to Buy)
2025-07-01−86,979→ 0 total
Disposition to Issuer
Inozyme Pharma, Inc.
Stock Option (Right to Buy)
2025-07-01−400,000→ 0 total
Disposition from Tender
Inozyme Pharma, Inc.
Common Stock
2025-07-01$4.00/sh−43,861→ 0 total
Disposition to Issuer
Inozyme Pharma, Inc.
Restricted Stock Units
2025-07-01−150,000→ 0 total
Award
Inozyme Pharma, Inc.
Common Stock
2025-06-25$0.74/sh+2,815→ 43,861 total
Award
CRISPR Therapeutics AG$CRSP
Stock Option (Right to Buy)
2025-06-05+13,000→ 13,000 total
Sale
Inozyme Pharma, Inc.
Common Stock
2025-04-02$0.89/sh−8,819→ 41,046 total
Exercise/Conversion
Inozyme Pharma, Inc.
Restricted Stock Units
2025-04-01−25,000→ 50,000 total
Exercise/Conversion
Inozyme Pharma, Inc.
Common Stock
2025-04-01+25,000→ 49,865 total
Award
Inozyme Pharma, Inc.
Restricted Stock Units
2025-03-11+100,000→ 100,000 total
Award
Inozyme Pharma, Inc.
Stock Option (right to buy)
2025-03-11+400,000→ 400,000 total
Award
Inozyme Pharma, Inc.
Common Stock
2024-09-30$4.45/sh+1,710→ 22,375 total
Award
CRISPR Therapeutics AG$CRSP
Stock Option (Right to Buy)
2024-05-30+13,000→ 13,000 total
Sale
Inozyme Pharma, Inc.
Common Stock
2024-04-02$6.94/sh−7,523→ 20,665 total
Exercise/Conversion
Inozyme Pharma, Inc.
Restricted Stock Units
2024-04-01−25,000→ 75,000 total
Exercise/Conversion
Inozyme Pharma, Inc.
Common Stock
2024-04-01+25,000→ 28,188 total
Award
Inozyme Pharma, Inc.
Stock Option (right to buy)
2024-03-13+300,000→ 300,000 total
Award
CRISPR Therapeutics AG$CRSP
Stock Option (Right to Buy)
2023-06-08+13,000→ 13,000 total
Award
Inozyme Pharma, Inc.
Stock option (right to buy)
2023-04-01+800,000→ 800,000 total
Award
Inozyme Pharma, Inc.
Restricted stock units
2023-04-01+100,000→ 100,000 total
Award
Inozyme Pharma, Inc.
Stock Option (right to buy)
2022-06-10+9,367→ 9,367 total
Award
CRISPR Therapeutics AG$CRSP
Stock Option (Right to Buy)
2022-06-09+12,000→ 12,000 total
Award
Inozyme Pharma, Inc.
Stock Option (right to buy)
2021-06-23+9,367→ 9,367 total
Award
CRISPR Therapeutics AG$CRSP
Stock Option (Right to Buy)
2021-06-10+10,000→ 10,000 total
Award
Inozyme Pharma, Inc.
Stock Option (right to buy)
2020-07-23+9,367→ 9,367 total
Award
CRISPR Therapeutics AG$CRSP
Stock Option (Right to Buy)
2020-06-11+30,000→ 30,000 total
Disposition to Issuer
Ra Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2020-04-02−164,285→ 0 total
Disposition to Issuer
Ra Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2020-04-02−225,000→ 0 total
Disposition to Issuer
Ra Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2020-04-02−125,000→ 0 total
Disposition to Issuer
Ra Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2020-04-02−241,460→ 0 total
Disposition to Issuer
Ra Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2020-04-02−139,371→ 0 total
Disposition to Issuer
Ra Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2020-04-02−311,000→ 0 total
Disposition to Issuer
Ra Pharmaceuticals, Inc.
Restricted Stock Units
2020-04-02−20,833→ 0 total
Disposition to Issuer
Ra Pharmaceuticals, Inc.
Common Stock
2020-04-02$48.00/sh−234,707→ 0 total
Exercise/Conversion
Ra Pharmaceuticals, Inc.
Restricted Stock Units
2019-02-01−20,834→ 41,666 total
Award
Ra Pharmaceuticals, Inc.
Options to Purchase Common Stock
2019-02-01+311,000→ 311,000 total
Tax Payment
Ra Pharmaceuticals, Inc.
COMMON STOCK
2019-02-01$21.00/sh−6,327→ 218,799 total
Exercise/Conversion
Ra Pharmaceuticals, Inc.
COMMON STOCK
2019-02-01+20,834→ 225,126 total
Award
Ra Pharmaceuticals, Inc.
Options to Purchase Common Stock
2018-02-01+125,000→ 125,000 total
Award
Ra Pharmaceuticals, Inc.
Restricted Stock Units
2018-02-01+62,500→ 62,500 total
Award
Ra Pharmaceuticals, Inc.
Options to Purchase Common Stock
2017-02-01+225,000→ 225,000 total

Companies

Recent Filings

Address

C/O INOZYME PHARMA, INC. 321 SUMMER STREET SUITE 400

BOSTON, MA, 02210

View on SEC.gov